2009年7月28日委员会决定,修订有关用于传统草药药品的草药、配制品以及化合物的清单(在文件C(2009) 5804中通报)

技术法规类型:欧盟Eurlex法规 来源:tbtmap

EURLEX ID:32010D0028

OJ编号:OJ L 11, 16.1.2010, p. 12-18

中文标题:2009年7月28日委员会决定,修订有关用于传统草药药品的草药、配制品以及化合物的清单(在文件C(2009) 5804中通报)

原文标题:Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance)

分类:13.30.15_医药产品

文件类型:二级立法 Decision|决定

废止日期:2058-12-31

法规全文:查看欧盟官方文件

EUR-Lex - 32010D0028 - EN
?

32010D0028


Title and reference

Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance)

?OJ L 11, 16.1.2010, p. 12–18 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

?BG?CS?DA?DE?EL?EN?ES?ET?FI?FR?HU?IT?LT?LV?MT?NL?PL?PT?RO?SK?SL?SV

Text

BG ES CS DA DE ET EL EN FR GA IT LV LT HU MT NL PL PT RO SK SL FI SV
html html html html html html html html html ? html html html html html html html html html html html html html
pdf pdf pdf pdf pdf pdf pdf pdf pdf ? pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf
tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff tiff

Dates

    of document: 28/07/2009
    of notification: 00/00/0000
    of effect: 00/00/0000; Entry into force Date notif.
    end of validity: 99/99/9999

Classifications

Miscellaneous information

  • Author:
    European Commission
  • Form:
    Decision
  • Addressee:
    Member States of the Community
  • Additional information:
    EEA relevance

Relationship between documents

Text

Bilingual display: BG CS DA DE EL EN ES ET FI FR HU IT LT LV MT NL PL PT RO SK SL SV

Commission Decision

of 28 July 2009

amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products

(notified under document C(2009) 5804)

(Text with EEA relevance)

(2010/28/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [1], and in particular Article 16(f) thereof,

Having regard to the opinions of the European Medicines Agency, formulated on 10 January 2008 and 6 March 2008 by the Committee for Herbal Medicinal Products,

Whereas:

(1) Calendula officinalis L and Pimpinella anisum L comply with the requirements set out in Directive 2001/83/EC. Calendula officinalis L and Pimpinella anisum L can be considered as herbal substances, herbal preparations or combinations thereof.

(2) It is therefore appropriate to include Calendula officinalis L and Pimpinella anisum L in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in Annex I to Commission Decision 2008/911/EC [2].

(3) Decision 2008/911/EC should therefore be amended accordingly.

(4) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,

HAS ADOPTED THIS DECISION:

Article 1

Decision 2008/911/EC is amended as follows:

1. Annex I is amended in accordance with Annex I to this Decision.

2. Annex II is amended in accordance with Annex II to this Decision.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 28 July 2009.

For the Commission

Günter Verheugen

Vice-President

[1] OJ L 311, 28.11.2001, p. 67.

[2] OJ L 328, 6.12.2008, p. 42.

--------------------------------------------------

ANNEX I

In Annex I to Decision 2008/911/EC, the following is inserted:

- "Calendula officinalis L" is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit),

- "Pimpinella anisum L" is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit).

--------------------------------------------------

ANNEX II

In Annex II to Decision 2008/911/EC, the following is inserted:

- "Calendula officinalis L" is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit)

"COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L

Scientific name of the plant

Calendula officinalis L.

Botanical family

Asteraceae

Herbal substance

Calendula flower

Common name in all EU official languages of herbal substance

BG (b?lgarski): Невен, цвят

CS (?e?tina): Měsí?kov? květ

DA (dansk): Morgenfrueblomst

DE (Deutsch): Ringelblumenblüten

EL (elliniká): ?νθο? καλ?ντουλα?

EN (English): Calendula flower

ES (espa?ol): Flor de caléndula

ET (eesti keel): Saialille?isik

FI (suomi): Tarhakeh?kukan kukka

FR (fran?ais): Souci

HU (magyar): A k?r?mvirág virága

IT (italiano): Calendula fiore

LT (lietuvi? kalba): Medetk? ?iedai

LV (latvie?u valoda): Kli??erītes ziedi

MT (malti): Fjura calendula

NL (nederlands): Goudsbloem

PL (polski): Kwiat nagietka

PT (português): Flor de calêndula

RO (rom?n?): Floare de g?lbenele (calendula)

SK (sloven?ina): Nechtíkov? kvet

SL (sloven??ina): Cvet vrtnega ognji?a

SV (svenska): Ringblomma, blomma

IS (íslenska): Morgunfrú, blóm

NO (norsk): Ringblomst

Herbal preparation(s)

A. Liquid extract (DER 1:1), extraction solvent ethanol 40-50 % (v/v).

B. Liquid extract (DER 1:1,8-2,2), extraction solvent ethanol 40-50 % (v/v).

C. Tincture (DER 1:5), extraction solvent ethanol 70-90 % (v/v).

European Pharmacopoeia monograph reference

Calendula flower – Calendulae flos (01/2005:1297)

Indication(s)

(a) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations of the skin (such as sunburn) and as an aid in healing of minor wounds.

(b) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations in the mouth or the throat.

The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.

Type of tradition

European

Specified strength

Please see "Specified posology".

Specified posology

Herbal preparations:

A. Liquid extract (DER 1:1)

In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.

B. Liquid extract (DER 1:1,8-2,2)

In semi-solid dosage forms: amount equivalent to 2-5 % herbal substance.

C. Tincture (DER 1:5)

In compresses diluted at least 1:3 with freshly boiled water.

In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.

As a gargle or mouth rinse in a 2 % solution.

2 to 4 times daily

Indication (a)

The use is not recommended in children under 6 years of age (see below "Special warnings and precautions for use").

Indication (b)

The use in children under 12 years of age is not recommended because there is no experience available (see below "Special warnings and precautions for use").

Route of administration

Cutaneous and oromucosal use.

Duration of use or any restrictions on the duration of use

Compresses: remove after 30-60 minutes

All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted.

Any other information necessary for the safe use

Contraindications

Hypersensitivity to members of the Asteraceae (Compositae) family.

Special warnings and precautions for use

Indication (a)

The use in children under 6 years of age is not recommended because there is no experience available.

Indication (b)

The use in children under 12 years of age is not recommended because there is no experience available.

If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted.

Interactions with other medicinal products and other forms of interaction

None reported.

Pregnancy and lactation

Safety during pregnancy and lactation has not been established.

In the absence of sufficient data, the use during pregnancy and lactation is not recommended.

Effects on ability to drive and use machines

Not relevant.

Undesirable effects

Skin sensitisation. The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.

Overdose

None reported."

- "Pimpinella anisum L" is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit)

"COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L

Scientific name of the plant

Pimpinella anisum L.

Botanical family

Apiaceae

Herbal substance

Aniseed

Common name in all EU official languages of herbal substance

BG (b?lgarski): Анасон, плод

CS (?e?tina): An?zov? plod

DA (dansk): Anisfr?

DE (Deutsch): Anis

EL (elliniká): Γλυκ?νισο

EN (English): Aniseed

ES (espa?ol): Fruto de anís

ET (eesti keel): Aniis

FI (suomi): Anis

FR (fran?ais): Anis (fruit d)

HU (magyar): ?nizsmag

IT (italiano): Anice (Anice verde), frutto

LT (lietuvi? kalba): Any?i? s?klos

LV (latvie?u valoda): Anīsa sēklas

MT (malti): Frotta tal-Anisi

NL (nederlands): Anijsvrucht

PL (polski): Owoc any?u

PT (português): Anis

RO (rom?n?): Fruct de anason

SK (sloven?ina): Anízov? plod

SL (sloven??ina): Plod vrtnega jane?a

SV (svenska): Anis

IS (íslenska): Anís

NO (norsk): Anis

Herbal preparation(s)

Dried aniseed, comminuted or crushed

European Pharmacopoeia monograph reference

Anisi fructus (01/2005:0262)

Indication(s)

(a) Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.

(b) Traditional herbal medicinal product used as an expectorant in cough associated with cold.

The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.

Type of tradition

European

Specified strength

Please see "Specified posology"

Specified posology

Adolescents over 12 years of age, adults, elderly:

Indications (a) and (b)

1 to 3,5 g of whole or (freshly [*]) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea

3 times daily

The use in children under 12 years is not recommended of age (see below "Special warnings and precautions for use").

Route of administration

Oral use

Duration of use or any restrictions on the duration of use

Not to be taken for more than 2 weeks.

If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

Any other information necessary for the safe use

Contraindications

Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) (caraway, celery, coriander, dill and fennel) or to anethole.

Special warnings and precautions for use

The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment.

Interactions with other medicinal products and other forms of interaction

None reported.

Pregnancy and lactation

There are no data from the use of aniseed in pregnant patients.

It is unknown if aniseed constituents are excreted in human breast milk.

In the absence of sufficient data, the use during pregnancy and lactation is not recommended.

Effects on ability to drive and use machines

No studies on the effect on the ability to drive and use machines have been performed.

Undesirable effects

Allergic reactions to aniseed affecting the skin or the respiratory system may occur. The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.

Overdose

No case of overdose has been reported.

[*] For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components."

--------------------------------------------------

Top

托管标准,您可以接收以下服务:

1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户;

2 随时在标准托管页面中查看到该条标准的最新状态;

3 若用户有在学习和科研中的需要,可以在标准托管页面中试阅标准;

4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持;

5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询;

6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务;

进入企业标准托管

您可以通过编辑查新模板,批量查询指定标准集的最新情况。我们会通过查询,向您展示您所查询标准的:

1. 准确的标准号及标准名称(我们通过人工智能技术对您提交的标准号进行自动纠正)

2. 标准的最新状态(现行、废止或未发布)

3. 若标准已废止并被新标准替代,会反馈被替代的标准

4. 若您已托管此标准,便可以实时跟踪这个标准的最新状态

标准查新 模板下载

您可以在这里检索全球超过140万条标准,支持上百个国内国际标准组织的标准查询。您也可以在这里检索国内各类国家、部委和地方的法律法规。

更多标准子库在持续建设中。

标准检索

标准资讯点击排行榜 全部

资讯标题点击

[[ n.title ]] [[ n.read ]]

大连标准化公共服务平台

版权:大连标准化研究院有限公司

地址:大连市中山区高原街56号

电话:0411-82740851

大连标准